Drusen, the hallmark of dry form of ARMD
, are situated between RPE and Bruch membrane and are mostly made of lipids (40%) and various proteins (9).
is in fact the greatest cause of blindness amongst people over the age of 50 and affects millions of people worldwide.
The results showed that taking the formulation reduced the risk of developing advanced ARMD
in people at a high risk for progression by about 25% over a five-year period.
Epidemiology suggests that the incidence and severity of ARMD
could be reduced if patients receive appropriate advice at the very earliest stages of disease," he said.
Research from the National Eye Institute has shown that combining zinc, vitamins C and E reduce the risk of ARMD
advances so slowly, often taking years to develop, that many people do not know they have it until it's at the intermediate stage, putting them at high risk for blindness.
Lifestyle modifications, vitamin supplementation, and low-vision aids can slow or mitigate the effects of ARMD
As shown in Table 3, a total of 199 patients had ARMD
(all types included).
We then identified disease cohorts for diabetes mellitus (DM) and ARMD
by searching for specific ICD-9-CM diagnosis codes (primary or secondary) on seven different types of Medicare claims files for the period 1984-1999: Carrier (Physician Supplier/Part B, 1991-1999 only), Outpatient, Inpatient, Skilled Nursing, Home Health Agency, and Hospice.
What he and other doctors do know is that smoking, high blood pressure, poor diet and over-exposure to sunlight increase the risk of getting ARMD
While one large study found that supplementing with these nutrients can delay progression of existing ARMD
, this research found that diet could help prevent the disease.
Observational and experimental data suggest that antioxidant or zinc supplements may delay progression of ARMD
and visual loss.
It's age-related macular degeneration, or ARMD
, an eye condition, and women are more often affected by it than men.
Because the baby boom generation is coming "of age," the prevalence of ARMD
is expected to increase to nearly three million Americans in the next 15 years.
CDS is expanding on this proven drug-delivery technology by combining it with known therapeutic compounds to treat a variety of other sight-threatening intraocular diseases, with an emphasis on retinal disorders, such as ARMD
, the deterioration of the central retina(a); and diabetic macular edema (DME), chronic deterioration and leakage of retinal blood vessels associated with diabetes.